Medscape

Case builds against routine ICD defibrillation-threshold testing

London, ON - Defibrillation-threshold (DFT) testing performed on a routine basis at ICD implantation is unlikely to significantly affect one- or five-year mortality, according to a statistical ...
Medscape

ICD plus antiarrhythmic drug therapy: Analysis doubts need for defibrillation threshold testing

Dallas, TX - Antiarrhythmic agents used with today's implantable cardioverter defibrillators (ICDs), particularly amiodarone, don't raise successful-shock energy requirements enough to make ...
Nature

Defibrillation testing unnecessary during routine cardioverter–defibrillator implantation

Defibrillation testing of implantable cardioverter–defibrillators (ICDs) does not improve outcomes compared with device implantation without testing and, therefore, “defibrillation testing during ...
Healio

SIMPLE: Defibrillation testing safe, but did not improve outcomes

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Routine defibrillation testing appears to be safe, but does not improve outcomes in patients ...
TCTMD

PRAETORIAN-DFT: Safe to Forgo Defibrillation Testing for S-ICD Implant

CHICAGO, IL—Defibrillation testing (DFT) is not always necessary in patients receiving a subcutaneous implantable cardioverter defibrillator (S-ICD) when using a scoring system that assesses the ...
Nature

Implantable Cardioverter-Defibrillator Performance and Therapy Optimization

Implantable cardioverter-defibrillators (ICDs) have transformed the management of patients at risk of sudden cardiac death by combining continuous rhythm monitoring with therapies that interrupt ...